What Is Your Medical Practice or ASC Worth? A 2026 Valuation Guide

If you own a medical practice or an ambulatory surgery center, the first question on your mind before any transaction is simple: what is my practice actually worth? The honest answer starts with a fact most owners find surprising — buyers do not pay for the number on your tax return. They pay for normalized earnings, applied against a market multiple, and the gap between those two figures is often measured in millions of dollars of enterprise value.

This guide walks through how buyers price physician practices and ASCs in 2026, what moves the multiple up or down, and how to prepare so you capture top-quartile value rather than leaving it on the table.

The core equation buyers actually use

Every practice valuation reduces to one relationship: Enterprise Value = Normalized EBITDA × Market Multiple. Two variables — and owners tend to obsess over the multiple while ignoring the normalization, which usually matters just as much.

Normalization means rebuilding your earnings to reflect what the business will actually produce after a change of control. That includes resetting owner compensation to a fair-market salary, removing one-time expenses, normalizing rent paid to related parties, and stress-testing every add-back you propose. A higher multiple applied to overstated earnings produces a worse outcome than a lower multiple on clean, defensible earnings.

2026 valuation multiples for physician practices

Physician practices generally trade in a range of 6–12× EBITDA, with smaller practices sometimes quoted at 0.5–1.0× revenue. Where a specific practice lands depends on size, specialty, and structure:

• Small, single-provider practices — roughly 5–7×, constrained by owner dependence and thin scale.
• Mid-size groups — roughly 7–9×, with more providers and transferable operations.
• High-provider-count platforms — 10× and above, rewarded for scale and management depth.
• Cardiology and ophthalmology — command premium multiples on durable demand and ancillary revenue.

Ancillary services lift the multiple meaningfully: ASC ownership can add 2–3 turns for surgical specialties, in-house imaging 1–2 turns, and integrated pathology or lab 0.5–1.5 turns.

2026 valuation multiples for ambulatory surgery centers

ASC transaction multiples reached an eight-year high in 2025. According to VMG Health's 2026 Healthcare M&A Report, the median total-invested-capital-to-EBITDA multiple for ASC transactions was 7.9×. Single-specialty centers typically trade at 5–8×, multispecialty centers at 6–10×, and regional or national operators with multiple centers can reach 11–17×.

Best-in-class centers with multiple locations, strong utilization, and favorable specialty mix (orthopedics, GI, retina, cardiology) achieve the top of the range. Single-site, single-specialty centers with out-of-network revenue concentration sit lower.

The 2026 Medicare wrinkle procedural practices must model

CMS finalized a 2026 conversion-factor increase but paired it with a −2.5% efficiency adjustment to work RVUs on roughly 7,000 procedural, imaging, and interventional codes. The net effect shifts value toward time-based specialties and away from procedural ones. If your practice is procedural, this can pressure the very EBITDA a buyer is capitalizing — model it before you go to market rather than discovering it in diligence.

How to prepare and capture top-quartile value

Industry advisors consistently recommend beginning sale preparation 2–3 years in advance. The practical work:

1. Clean the financials first — accurate books and clear EBITDA visibility are the single biggest lever on price.
2. Reduce owner dependence — document processes so the practice doesn't rely on the founder.
3. Strengthen the value drivers — provider retention, employment agreements, revenue-cycle discipline, and location-level reporting.
4. Choose the right path — immediate sale, delayed sale after preparation, majority recapitalization, or minority investment.